Background and Study Aims: Controversy exists as to whether all patients with lower intestinal bleeding need to undergo total colonoscopy. This study compares the prevalence of colonic neoplasms in patients reporting scant hematochezia with the prevalence in controls.
Patients and Methods: Structured interviews were carried out with 4265 consecutive patients referred for colonoscopy. Of these, 468 patients had scant hematochezia, 299 had occult rectal bleeding and 57 reported dark rectal bleeding. Patients with scant hematochezia were matched for age and sex with those having no risk factors for colorectal neoplasms. For all groups, we determined the prevalence of adenomas and cancers below and above 50 cm.
Results: Colonic neoplasms were found in 18 % of patients with scant hematochezia and in 7.5 % of controls. However, most of these tumors were located within the reach of a sigmoidoscope. Compared with controls, patients with scant hematochezia had no increased risk for proximal neoplasms (odds ratio [OR] = 1.2), while this risk was significantly increased in patients with occult rectal bleeding (OR = 3.1) and patients who had observed maroon-colored blood in their stool (OR = 4.8).
Conclusions: Flexible sigmoidoscopy appears to be a sufficient work-up for young patients who have observed trace amounts of bright red blood on the surface of their stool.
References
-
1
Farrands P A, Hardcastle J D, Chamberlain J, Moss S.
Factors affecting compliance with screening for colorectal cancer.
Community Med.
1984;
6
12-19
-
2
Farrands P A, Hardcastle J D.
Colorectal screening by a self-completion questionnaire.
Gut.
1984;
25
445-447
-
3
Chapuis P H, Goulston K J, Dent O F, Tait A D.
Predictive value of rectal bleeding in screening for rectal and sigmoid polyps.
Br Med J.
1985;
290
1546-1548
-
4
Dent O F, Goulston K J, Zubrzycki J, Chapuis P H.
Bowel symptoms in an apparently well population.
Dis Colon Rectum.
1986;
29
243-247
-
5
Talley N J, Jones M.
Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking.
Am J Gastroenterol.
1998;
93
2179-2183
-
6
Crossland A, Jones R.
Rectal bleeding: prevalence and consultation behaviour.
Br Med J.
1995;
311
486-488
-
7
Silman A J, Mitchell P, Nicholls R J. et al .
Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Br J Surg.
1983;
70
721-724
-
8
Lieberman D A, de Garmo P L, Fleischer D E. et al .
Patterns of endoscopy use in the United States.
Gastroenterology.
2000;
118
619-624
-
9
Helfand M, Marton K I, Zimmer-Gembeck M J, Sox H C.
History of visible rectal bleeding in a primary care population. Initial assessment and 10-year follow-up.
JAMA.
1997;
277
44-48
-
10
Goulston K J, Cook I, Dent O F.
How important is rectal bleeding in the diagnosis of bowel cancer and polyps?.
Lancet.
1986;
2
261-264
-
11
Swarbrick E T, Fevre D I, Hunt R H. et al .
Colonoscopy for unexplained rectal bleeding.
Br Med J.
1978;
2
1685-1687
-
12
Graham D J, Pritchard T J, Bloom A D.
Colonoscopy for intermittent rectal bleeding: impact on patient management.
J Surg Res.
1993;
54
136-139
-
13
Acosta J A, Fournier T K, Knutson C O, Ragland J J.
Colonoscopic evaluation of rectal bleeding in young adults.
Am Surg.
1994;
60
903-906
-
14
American Society for Gastrointestinal Endoscopy.
The role of endoscopy in the patient with lower gastrointestinal bleeding.
Gastrointest Endosc.
1998;
48
685-688
-
15
Gonvers J-J, de Bosset V, Froehlich F. et al .
Appropriateness of colonoscopy: hematochezia.
Endoscopy.
1999;
31
631-636
-
16
Segal W N, Greenberg P D, Rockey D C. et al .
The outpatient evaluation of hematochezia.
Am J Gastroenterol.
1998;
93
179-182
-
17
Van Rosendaal G MA, Sutherland L R, Verhoef M J. et al .
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding.
Am J Gastroenterol.
2000;
95
1184-1187
-
18
Silman A J, Mitchell P, Nicholls R J. et al .
Self-reported dark rectal bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Br J Surg.
1983;
70
721-724
V. F. Eckardt
Deutsche Klinik für Diagnostik
Aukammallee 33 · 65191 Wiesbaden · Germany ·
Fax: + 49-611-577401
Email: eckardt.gastro2@dkd-wiesbaden.de
